Andrew Bryant

6PUBLICATIONS
50CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cardiovascular medicine and haematology not elsewhere classifiedEpidemiological methodsEpidemiological modellingPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 29, 2026
Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced epithelial ovarian cancer.

|Mar 03, 2026
Clinical and cost-effectiveness of eculizumab withdrawal in atypical haemolytic uraemic syndrome: the SETS aHUS multi-centre, open-label, prospective and single-arm study.

Andrew Bryant, Jan Lecouturier, Giovany Orozco-Leal

|Jun 27, 2023
Current practices in studies applying the target trial emulation framework: a protocol for a systematic review.

Theophile Bigirumurame, Shaun Kuan Wei Hiu, M Dawn Teare

|Aug 29, 2022
Residual disease after primary surgery for advanced epithelial ovarian cancer: expert elicitation exercise to explore opinions about potential impact of publication bias in a planned systematic review and meta-analysis.

Andrew Bryant, Michael Grayling, Shaun Hiu

|Nov 18, 2021
Optimal surveillance strategies for patients with stage 1 cutaneous melanoma post primary tumour excision: three systematic reviews and an economic model.

Luke Vale, Patience Kunonga, Diarmuid Coughlan

|Jun 19, 2021
Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines.

Andrew Bryant, Theresa A Lawrie, Therese Dowswell

Pageof 1

Frequent Collaborators

2 joint publications

Luke Vale

1 joint publications

Patience Kunonga

1 joint publications

Diarmuid Coughlan

1 joint publications

Vasileios Kontogiannis